WST vs XERS · P/E 35, rev $1.72B vs rev $175.2M
West Pharmaceutical Services Inc (WST) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
WST currently screens at market cap $15.97B and trailing P/E 34.8. XERS currently screens at market cap $760.7M.
Not investment advice. Open the WST and XERS stock pages for the full models.
Not investment advice.